Allarity Therapeutics, Inc. Share Price Nasdaq Stockholm
Equities
ALLR
US0167441049
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 423K 4.6M 35.31M |
---|---|---|---|---|---|
Net income 2024 * | -16M -174M -1.33B | Net income 2025 * | -28M -304M -2.34B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.05
x | P/E ratio 2025 * |
-0.05
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 12.94% |
Latest transcript on Allarity Therapeutics, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Thomas Jensen
FOU | Founder | 46 | 01/20/01 |
Joan Brown
DFI | Director of Finance/CFO | 71 | 21/21/21 |
Chief Tech/Sci/R&D Officer | 63 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 56 | 01/22/01 | |
Thomas Jensen
FOU | Founder | 46 | 01/20/01 |
Joseph Vazzano
BRD | Director/Board Member | 40 | 01/23/01 |
1st Jan change | Capi. | |
---|---|---|
-1.36% | 104B | |
+6.73% | 97.47B | |
+5.71% | 22.25B | |
-12.50% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-9.94% | 16.36B | |
+7.89% | 14.39B | |
+37.07% | 12.37B |